サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1170927

DNAメチル化の市場規模、シェア、動向分析レポート：技術別（PCR、マイクロアレイ、シーケンス）、用途別（遺伝子治療、診断）、製品別、最終用途別、地域別、およびセグメント別予測、2022年～2030年

DNA Methylation Market Size, Share & Trends Analysis Report By Technology (PCR, Microarray, Sequencing), By Application (Gene Therapy, Diagnostics), By Product, By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
DNAメチル化の市場規模、シェア、動向分析レポート：技術別（PCR、マイクロアレイ、シーケンス）、用途別（遺伝子治療、診断）、製品別、最終用途別、地域別、およびセグメント別予測、2022年～2030年
出版日: 2022年11月09日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

DNAメチル化市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界のDNAメチル化市場規模は2030年までに42億2000万米ドルに達すると予測されています。この市場は、シーケンス解析におけるDNAメチル化の利用が増加していることから、2022年から2030年にかけて14.67%のCAGRを記録すると予測されています。アグリゲノミクス分野におけるDNAメチル化の採用が増加していることは、この成長の有望な促進要因であり続けています。

2020年1月、Springerに掲載された研究誌に、DNAメチル化および発現解析により、ピーナッツの葉面病耐性遺伝子にエピアルルがあることが示されたと記載されています。DNAメチル化解析は、研究者、製薬会社にとって新たな機会の扉を開き続けています。この分野での研究開発の増加は、今後数年間、DNAメチル化産業をさらに牽引するものと思われます。

さらに、食道腺がんの有病率の増加が、全体の成長に寄与しています。米国がん協会（ACS）が発表したデータによると、2022年、米国では推定20,640件の食道がんが未診断であり、この慢性疾患により16,410人が死亡しています。

米国で増加する食道がん症例は、患者の低い生存率を改善するための早期介入策の緊急性を浮き彫りにしています。2022年10月、フレッド・ハッチンソンがんセンターが発表した研究論文では、メチル化DNAバイオマーカーが食道腺がんや高悪性度異形成の検出に利用できることが述べられています。

エピジェネティクスに基づく治療戦略の採用が大幅に増加し、幅広い核酸ベースの診断テスト＆キットの商業化が相まって、市場の成長を促進すると予測されます。2022年5月、PubMedに掲載された論文によると、エピジェネティクスに基づく治療戦略は、アルツハイマー病の研究に使用される予定であることが記載されています。しかし、DNAメチル化実験を行うための専門知識の欠如が、成長を制限する可能性があります。DNAメチル化は、さまざまなバイオテクノロジー応用において大きな可能性を秘めていますが、熟練した専門家の数が比較的少ないことが、依然として成長の障害となっています。

市場で事業を展開する主な企業は、新製品の開発や戦略的提携の締結、地域的拡大など、いくつかの取り組みを行っています。例えば、2022年5月、オックスフォード・ナノポアは、正確でリアルタイムのエピジェネティックな洞察を提供する技術であるRemoraをナノポアシーケンスソフトウェアと統合することを発表しました。これにより、さらに正確な全ゲノムメチル化検出への簡単なアクセスが可能になります。同様に、2020年6月、Base Genomics社は、DNAメチル化技術の進歩と発展を発表しました。その目的は、血液検査から大量のエピジェネティックデータをシーケンスすることであり、予防医学の分野に革命を起こす可能性があります。

DNAメチル化市場のレポートハイライト

分子生物学、ゲノミクス、アグリゲノミクス分野におけるシーケンス解析でDNAメチル化の採用が進んでいることが全体の成長の要因です。

技術別では、多くの市場参加者が研究目的でシーケンシング技術を採用するようになっていることから、2021年にはシーケンシングセグメントが最も高いシェアを占めた

製品別では、DNAシーケンシングの手順や診断プロセスで主に使用される消耗品セグメントが市場を独占した

アプリケーション別では、世界的に様々な疾患の臨床試験数が増加していること、また政府による継続的な支援により研究開発費が増加していることから、臨床研究分野が市場を席巻しています。

エンドユーザー別では、製薬会社やバイオテクノロジー会社が市場を独占しており、これは主要な市場プレーヤーによるNGSなどのハイスループット技術の利用が増加しているためです

製造および研究開発施設の幅広いネットワークにより、2021年には北米が市場を独占。製品の発売数の増加、FDAの承認、主要な市場プレイヤーの存在は、この地域の有望な成長要因であり続けている

目次

第1章 DNAメチル化市場：調査手法と範囲

  • 市場セグメンテーション
    • セグメントの範囲
    • 地域範囲
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • Gvrの内部データベース
    • 二次情報
    • 1次調査
    • 1次調査の詳細
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析
      • アプローチ1：コモディティフローアプローチ
      • アプローチ2：ボトムアップアプローチを使用した国ごとの市場予測
      • アプローチ2：トップダウンアプローチを使用した国ごとの市場推定
  • 世界市場：CAGR計算
  • 地域市場：CAGR計算
  • 二次情報のリスト
  • 目的
  • 略語一覧

第2章 DNAメチル化市場：エグゼクティブサマリー

  • DNAメチル化市場：市場の見通し
    • 市場概要

第3章 DNAメチル化市場：業界の展望

  • 市場系列の見通し
    • 親市場系統の見通し
    • 関連/補助的な市場の見通し
  • 浸透と成長の見通しのマッピング
  • 市場力学
    • 市場促進要因
      • 腫瘍学調査におけるDNAメチル化技術の採用の増加
      • がんの有病率が世界的に増加
      • エピジェネティックなバイオマーカーとしてのDNAメチル化の採用の増加
    • 市場抑制要因分析
      • DNAメチル化実験を実施するための専門知識とバイオテクノロジーの知識の欠如
      • 商用診断検査としてのDNAメチル化の採用の減少
  • SWOT分析、要因別（政治と法律、経済と技術）
  • 業界分析- ポーターズ
  • 償還と規制のシナリオ
  • 主要取引と戦略的提携
    • 新製品の発売
    • 取得
    • 拡張
    • パートナーシップ
    • マーケティングとプロモーション

第4章 DNAメチル化市場：競合情勢

  • 主要な市場参入企業別最近の動向と影響分析
    • アンゾフのマトリクス
  • 会社の分類
    • イノベーター
      • 市場の差別化要因
  • ベンダー情勢
    • 主要なディストリビューターとチャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2021年
  • 公開会社
    • 競合ダッシュボード分析
  • 非公開会社
    • 主要な新興企業のリスト
  • 地域のネットワークマップ

第5章 DNAメチル化市場：テクノロジービジネス分析

  • DNAメチル化市場：技術変動分析
  • ポリメラーゼ連鎖反応（PCR）
  • マイクロアレイ
  • シーケンシング
  • その他

第6章 DNAメチル化市場：製品ビジネス分析

  • DNAメチル化市場：製品変動分析
  • 消耗品
  • キットと試薬
  • 酵素
  • 計測器とソフトウェア

第7章 DNAメチル化市場：アプリケーションビジネス分析

  • DNAメチル化市場：アプリケーションの変動分析
  • 遺伝子治療
  • 臨床調査
  • 診断
  • その他

第8章 DNAメチル化市場：エンドユースビジネス分析

  • DNAメチル化市場：最終用途の変動分析
  • 病院および診断検査室
  • 製薬およびバイオテクノロジー企業
  • 調査と学術

第9章 DNAメチル化市場：地域ビジネス分析

  • 国別の市場シェア分析、2021年および2030年
    • 北米
      • 米国
      • カナダ
    • 欧州
      • 英国
      • ドイツ
      • フランス
      • イタリア
      • スペイン
    • アジア太平洋
      • 日本
      • 中国
      • インド
      • 韓国
      • オーストラリア
    • ラテンアメリカ
      • ブラジル
      • メキシコ
      • アルゼンチン
    • 中東とアフリカ
      • 南アフリカ
      • サウジアラビア
      • アラブ首長国連邦

第10章 DNAメチル化市場：企業プロファイリング

  • 企業プロファイル
    • New England Biolabs
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Sysmex Corporation
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Abcam plc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • F. Hoffmann-La Roche Ltd.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Diagenode Diagnostics SA
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Thermo-Fisher Scientific Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Agilent Technologies Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • BioRad Laboratories Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Exact Sciences Corporation
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • QIAGEN NV
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • QIAGEN NV
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Active Motif, Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Illumina Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • EpiGentek Group Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Pacific Biosciences Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • New England Biolabs Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Merck KGaA
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • Zymo Research Corporation
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
    • PerkinElmer Inc.
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的イニシアチブ
  • その他の主なプレーヤーのリスト
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 4 Global DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 7 Global DNA Methylation Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America DNA Methylation Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 10 North America DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 12 North America DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 13 U.S. DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 14 U.S. DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 15 U.S. DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 U.S. DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 17 Canada DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 18 Canada DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Canada DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Canada DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 21 Europe DNA Methylation Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Europe DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 24 Europe DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 25 Europe DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 26 Germany DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 27 Germany DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 28 Germany DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Germany DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 30 U.K. DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 31 U.K. DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 U.K. DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 U.K. DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 34 France DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 35 France DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 France DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 France DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 38 Italy DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 39 Italy DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 40 Italy DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 Italy DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 42 Spain DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 43 Spain DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 44 Spain DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 45 Spain DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific DNA Methylation Market, by Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 51 China DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 52 China DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 53 China DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 54 China DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 55 Japan DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 56 Japan DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 Japan DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 Japan DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 59 India DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 India DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 61 India DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 India DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 63 Australia DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 64 Australia DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 65 Australia DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 66 Australia DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 67 South Korea DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 68 South Korea DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 69 South Korea DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 South Korea DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 71 Latin America DNA Methylation Market, by Country, 2018 - 2030 (USD Million)
  • Table 72 Latin America DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Latin America DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 74 Latin America DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 75 Latin America DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 76 Brazil DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 77 Brazil DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 78 Brazil DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 79 Brazil DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 80 Mexico DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 81 Mexico DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 82 Mexico DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 83 Mexico DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 84 Argentina DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 85 Argentina DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 86 Argentina DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 Argentina DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 88 Middle East & Africa DNA Methylation Market, by Country, 2018 - 2030 (USD Million)
  • Table 89 Middle East & Africa DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 90 Middle East & Africa DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 91 Middle East & Africa DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 92 Middle East & Africa DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 93 South Africa DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 94 South Africa DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 95 South Africa DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 96 South Africa DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 97 Saudi Arabia DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 98 Saudi Arabia DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 99 Saudi Arabia DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 100 Saudi Arabia DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)
  • Table 101 UAE DNA Methylation Market, by Technology, 2018 - 2030 (USD Million)
  • Table 102 UAE DNA Methylation Market, by Product, 2018 - 2030 (USD Million)
  • Table 103 UAE DNA Methylation Market, by Application, 2018 - 2030 (USD Million)
  • Table 104 UAE DNA Methylation Market, by End - use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain - Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 DNA Methylation, Market Segmentation
  • Fig. 8 Market Snapshot, 2021
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 16 Global DNA Methylation Market : Technology Movement Analysis
  • Fig. 17 Global DNA Methylation Market, for Polymerase Chain Reaction (PCR), 2018 - 2030 (USD Million)
  • Fig. 18 Global DNA Methylation Market, for Microarray, 2018 - 2030 (USD Million)
  • Fig. 19 Global DNA Methylation Market, for Sequencing, 2018 - 2030 (USD Million)
  • Fig. 20 Global DNA Methylation Market, for Other, 2018 - 2030 (USD Million)
  • Fig. 21 Global DNA Methylation Market: Product Movement Analysis
  • Fig. 22 Global DNA Methylation Market, for Kits & Reagents, 2018 - 2030 (USD Million)
  • Fig. 23 Global DNA Methylation Market, for Enzymes, 2018 - 2030 (USD Million)
  • Fig. 24 Global DNA Methylation Market, for Instrument and software, 2018 - 2030 (USD Million)
  • Fig. 25 Global DNA Methylation Market: Application Movement Analysis
  • Fig. 26 Global DNA Methylation Market, for Gene Therapy, 2018 - 2030 (USD Million)
  • Fig. 27 Global DNA Methylation Market, for Clinical Research, 2018 - 2030 (USD Million)
  • Fig. 28 Global DNA Methylation Market, for Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 29 Global DNA Methylation Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 30 Global DNA Methylation Market: End - use Movement Analysis
  • Fig. 31 Global DNA Methylation Market, for Hospital & Diagnostic laboratories, 2018 - 2030 (USD Million)
  • Fig. 32 Global DNA Methylation Market, for Pharmaceutical & Biotechnology companies, 2018 - 2030 (USD Million)
  • Fig. 33 Global DNA Methylation Market, for Research & Academia, 2018 - 2030 (USD Million)
  • Fig. 34 Regional Marketplace: Key Takeaways
  • Fig. 35 Regional Outlook, 2021 & 2030
  • Fig. 36 Global DNA Methylation Market: Region Movement Analysis
  • Fig. 37 North America DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 41 Germany DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 42 U.K. DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 43 France DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 47 Japan DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 48 China DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 49 India DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 50 Australia DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 59 UAE DNA Methylation Market, 2018 - 2030 (USD Million)
  • Fig. 60 Ansoff Matrix
  • Fig. 61 Market differentiators
  • Fig. 62 Key company market share analysis, 2021
  • Fig. 63 Company market position analysis
  • Fig. 64 Competitive dashboard analysis
  • Fig. 65 Regional network map
目次
Product Code: GVR-4-68039-996-4

DNA Methylation Market Growth & Trends:

The global DNA methylation market size is expected to reach USD 4.22 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 14.67% from 2022 to 2030, due to the increased usage of DNA methylation in sequencing analysis. The increased adoption of DNA methylation in the agrigenomics field remains a promising driver of this growth.

In January 2020, a research journal published in Springer stated that DNA methylation and expression analysis shows peanut foliar disease resistance genes have epialleles. DNA methylation analysis continues to open new doors of opportunities for researchers, and pharmaceutical companies. Increased research and developments in this field would further drive the DNA methylation industry in the coming years.

Furthermore, the growing prevalence of esophageal adenocarcinoma has contributed to the overall growth. According to the data published by the American Cancer Society (ACS), in 2022, an estimated 20,640 esophageal cancer cases were undiagnosed in the U.S. The chronic disease. resulted in 16,410 deaths.

Growing esophageal cancer cases in the U.S. highlight the urgent need for early intervention measures that can help improve the low survival rates for patients. In October 2022, a research article published by Fred Hutchinson Cancer Center stated that methylated DNA biomarkers could be used for the detection of esophageal adenocarcinoma and high-grade dysplasia.

The significant increase in the adoption of epigenetics-based treatment strategies, coupled with the broad nucleic acid-based diagnostic tests & kits commercialization is projected to drive the growth of the market. In May 2022, an article published in PubMed stated that theepigenetics-based treatment strategies are to be used for studying Alzheimer's disease. However, a lack of expertise to perform DNA methylation experiments could restrict the growth. DNA methylation holds significant potential in various biotechnology applications, while the relatively low number of skilled professionals remains an obstacle to growth.

Key players operating in the market are taking several initiatives such as new product developments, entering into a strategic alliance, and regional expansion among others. For instance, in May 2022, Oxford Nanopore announced integrating Remora, a technique that offers accurate and real-time epigenetic insights with nanopore sequencing software. This would further offer simple access to accurate whole genome methylation detection. Similarly, in June 2020, Base Genomics announced of advancing and developing its DNA methylation technology. the aim is to sequence a large amount of epigenetic data from a blood test which could revolutionize the preventative medicine arena.

DNA Methylation Market Report Highlights:

  • The overall growth is attributed to the growing adoption of DNA methylation in sequencing analysis in the molecular biology and genomics and agrigenomics fields
  • By technology, the sequencing segment captured the highest share in 2021, owing to the increasing adoption of sequencing technology for research purposes by numerous market players
  • By product, the consumables segment dominated the market as it is majorly used in the DNA sequencing procedures and diagnosis process
  • By application, the clinical research segment dominated the market due to the rising number of clinical trials for various diseases globally, and constant government support leading to increasing R&D expenditure
  • By end use, pharmaceutical and biotechnology companies dominated the market, thanks to the increasing usage of high throughput technologies such as NGS by key market players
  • North America dominated the market in 2021 due to the wide network of manufacturing and R&D facilities. The growing number of product launches, FDA approvals, and the presence of key market players remains a promising driver of growth in this region

Table of Contents

Chapter 1 DNA Methylation Market: Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
      • 1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Regional Market: CAGR Calculation
  • 1.9 List Of Secondary Sources
  • 1.10 Objectives
    • 1.10.1 Objective 1:
    • 1.10.2 Objective 2:
  • 1.11 List of Abbreviations

Chapter 2 DNA Methylation Market: Executive Summary

  • 2.1 DNA Methylation Market: Market Outlook
    • 2.1.1 Market Summary

Chapter 3 DNA Methylation Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Increasing adoption of DNA methylation technology in oncology research
      • 3.3.1.2 Growing prevalence of cancer globally
      • 3.3.1.3 Increasing adoption of DNA methylation as epigenetic biomarkers
    • 3.3.2 Market restraint Analysis
      • 3.3.2.1 Lack of expertise and biotechnological knowledge to conduct DNA methylation experiments
      • 3.3.2.2 Less adoption of DNA methylation as a commercial diagnostic test
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions

Chapter 4 DNA Methylation Market: Competitive Landscape

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 4.1.1 Ansoff Matrix
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List Of Key Distributors And Channel Partners
    • 4.3.2 Key Customers
    • 4.3.3 Key Company Market Share Analysis, 2021
  • 4.4 Public Companies
    • 4.4.1 Competitive Dashboard Analysis
  • 4.5 Private Companies
    • 4.5.1 List Of Key Emerging Companies
  • 4.6 Regional Network Map

Chapter 5 DNA Methylation Market: Technology Business Analysis

  • 5.1 DNA Methylation Market: Technology Movement Analysis
  • 5.2 Polymerase Chain Reaction (PCR)
    • 5.2.1 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3 Microarray
    • 5.3.1 Microarray market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4 Sequencing
    • 5.4.1 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 DNA Methylation Market: Product Business Analysis

  • 6.1 DNA Methylation Market: Product Movement Analysis
  • 6.2 Consumables
    • 6.2.1 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3 Kits & Reagents
    • 6.3.1 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4 Enzymes
    • 6.4.1 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5 Instruments & Software
    • 6.5.1 Instruments & software market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 DNA Methylation Market: Application Business Analysis

  • 7.1 DNA Methylation Market: Application Movement Analysis
  • 7.2 Gene therapy
    • 7.2.1 Gene therapy market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.3 Clinical Research
    • 7.3.1 Clinical research market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4 Diagnostics
    • 7.4.1 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5 Others
    • 7.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 DNA Methylation Market: End-use Business Analysis

  • 8.1 DNA Methylation Market: End-use Movement Analysis
  • 8.2 Hospital & Diagnostic Laboratories
    • 8.2.1 Hospital & diagnostic laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.3 Pharmaceutical & Biotechnology Companies
    • 8.3.1 Pharmaceutical & biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
  • 8.4 Research & Academia
    • 8.4.1 Research & academia market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 DNA Methylation Market: Regional Business Analysis

  • 9.1 Market Share Analysis by Country, 2021 & 2030
    • 9.1.1 North America
      • 9.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.1.2 U.S.
      • 9.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.1.3 Canada
      • 9.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.2 Europe
      • 9.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.2 U.K.
      • 9.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.3 Germany
      • 9.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.4 France
      • 9.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.5 Italy
      • 9.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.2.6 Spain
      • 9.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.3 Asia-Pacific
      • 9.1.3.1 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.2 Japan
      • 9.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.3 China
      • 9.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.4 India
      • 9.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.5 South Korea
      • 9.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.3.6 Australia
      • 9.1.3.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.4 Latin America
      • 9.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.4.2 Brazil
      • 9.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.4.3 Mexico
      • 9.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.4.4 Argentina
      • 9.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.1.5 Middle East & Africa
      • 9.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.5.2 South Africa
      • 9.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.5.3 Saudi Arabia
      • 9.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
      • 9.1.5.4 UAE
      • 9.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10 DNA Methylation Market: Company Profiling

  • 10.1 Company Profiles
    • 10.1.1 New England Biolabs
      • 10.1.1.1 Company overview
      • 10.1.1.2 Financial performance
      • 10.1.1.3 Product benchmarking
      • 10.1.1.4 Strategic initiatives
    • 10.1.2 Sysmex Corporation
      • 10.1.2.1 Company overview
      • 10.1.2.2 Financial performance
      • 10.1.2.3 Product benchmarking
      • 10.1.2.4 Strategic initiatives
    • 10.1.3 Abcam plc.
      • 10.1.3.1 Company overview
      • 10.1.3.2 Financial performance
      • 10.1.3.3 Product benchmarking
      • 10.1.3.4 Strategic initiatives
    • 10.1.4 F. Hoffmann-La Roche Ltd.
      • 10.1.4.1 Company overview
      • 10.1.4.2 Financial performance
      • 10.1.4.3 Product benchmarking
      • 10.1.4.4 Strategic initiatives
    • 10.1.5 Diagenode Diagnostics S.A.
      • 10.1.5.1 Company overview
      • 10.1.5.2 Financial performance
      • 10.1.5.3 Product benchmarking
      • 10.1.5.4 Strategic initiatives
    • 10.1.6 Thermo-Fisher Scientific Inc.
      • 10.1.6.1 Company overview
      • 10.1.6.2 Financial performance
      • 10.1.6.3 Product benchmarking
      • 10.1.6.4 Strategic initiatives
    • 10.1.7 Agilent Technologies Inc.
      • 10.1.7.1 Company overview
      • 10.1.7.2 Financial performance
      • 10.1.7.3 Product benchmarking
      • 10.1.7.4 Strategic initiatives
    • 10.1.8 BioRad Laboratories Inc.
      • 10.1.8.1 Company overview
      • 10.1.8.2 Financial performance
      • 10.1.8.3 Product benchmarking
      • 10.1.8.4 Strategic initiatives
    • 10.1.9 Exact Sciences Corporation
      • 10.1.9.1 Company overview
      • 10.1.9.2 Financial performance
      • 10.1.9.3 Product benchmarking
      • 10.1.9.4 Strategic initiatives
    • 10.1.10 QIAGEN N.V.
      • 10.1.10.1 Company overview
      • 10.1.10.2 Financial performance
      • 10.1.10.3 Product benchmarking
      • 10.1.10.4 Strategic initiatives
    • 10.1.11 QIAGEN N.V.
      • 10.1.11.1 Company overview
      • 10.1.11.2 Financial performance
      • 10.1.11.3 Product benchmarking
      • 10.1.11.4 Strategic initiatives
    • 10.1.12 Active Motif, Inc.
      • 10.1.12.1 Company overview
      • 10.1.12.2 Financial performance
      • 10.1.12.3 Product benchmarking
      • 10.1.12.4 Strategic initiatives
    • 10.1.13 Illumina Inc.
      • 10.1.13.1 Company overview
      • 10.1.13.2 Financial performance
      • 10.1.13.3 Product benchmarking
      • 10.1.13.4 Strategic initiatives
    • 10.1.14 EpiGentek Group Inc.
      • 10.1.14.1 Company overview
      • 10.1.14.2 Financial performance
      • 10.1.14.3 Product benchmarking
      • 10.1.14.4 Strategic initiatives
    • 10.1.15 Pacific Biosciences Inc.
      • 10.1.15.1 Company overview
      • 10.1.15.2 Financial performance
      • 10.1.15.3 Product benchmarking
      • 10.1.15.4 Strategic initiatives
    • 10.1.16 New England Biolabs Inc.
      • 10.1.16.1 Company overview
      • 10.1.16.2 Financial performance
      • 10.1.16.3 Product benchmarking
      • 10.1.16.4 Strategic initiatives
    • 10.1.17 Merck KGaA
      • 10.1.17.1 Company overview
      • 10.1.17.2 Financial performance
      • 10.1.17.3 Product benchmarking
      • 10.1.17.4 Strategic initiatives
    • 10.1.19 Zymo Research Corporation
      • 10.1.18.1 Company overview
      • 10.1.18.2 Financial performance
      • 10.1.18.3 Product benchmarking
      • 10.1.18.4 Strategic initiatives
    • 10.1.19 PerkinElmer Inc.
      • 10.1.19.1 Company overview
      • 10.1.19.2 Financial performance
      • 10.1.19.3 Product benchmarking
      • 10.1.19.4 Strategic initiatives
  • 10.2 List of Other Key Players